drugset / Trial / NCT00466102
Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine wether RAD001 can inhibit growth of tumour cells and/or stop the formation and activity of bone degrading osteoclasts.
Timeline
- Start
- 2006-12
- Primary completion
- 2010-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Everolimus | Small molecule | 10 mg | Oral |